JFNIX
Price
$70.64
Change
+$0.56 (+0.80%)
Updated
Sep 5 closing price
Net Assets
4.28B
LHCCX
Price
$19.10
Change
+$0.15 (+0.79%)
Updated
Sep 8 closing price
Net Assets
7.85M
Interact to see
Advertisement

JFNIX vs LHCCX

Header iconJFNIX vs LHCCX Comparison
Open Charts JFNIX vs LHCCXBanner chart's image
Janus Henderson Global Life Sciences I
Price$70.64
Change+$0.56 (+0.80%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care C
Price$19.10
Change+$0.15 (+0.79%)
VolumeN/A
Net Assets7.85M
JFNIX vs LHCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCCX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. LHCCX (7.85M). JFNIX pays higher dividends than LHCCX: JFNIX (0.39) vs LHCCX (0.00). JFNIX was incepted earlier than LHCCX: JFNIX (16 years) vs LHCCX (6 years). LHCCX (4.09) is less costly to investors than JFNIX (0.77). LHCCX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCCX has a lower initial minimum investment than JFNIX: LHCCX (1500) vs JFNIX (2500). LHCCX annual gain was more profitable for investors over the last year : -1.97 vs. JFNIX (-12.88). JFNIX return over 5 years is better than : 10.19 vs. LHCCX (5.22).
JFNIXLHCCXJFNIX / LHCCX
Total Expense Ratio0.771.7843%
Annual Report Gross Expense Ratio0.774.0919%
Fund Existence16 years6 years-
Gain YTD3.8522.989129%
Front LoadN/AN/A-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.85M54,607%
Annual Yield % from dividends0.390.00-
Returns for 1 year-12.88-1.97655%
Returns for 3 years17.0216.33104%
Returns for 5 years10.195.22195%
Returns for 10 years22.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJPTX14.960.14
+0.94%
VY® JPMorgan Emerging Markets Equity S2
PGLEX19.150.09
+0.47%
Putnam Focused International Equity R6
FFANX13.970.04
+0.29%
Fidelity Asset Manager 40%
OMGCX27.10N/A
N/A
JPMorgan Mid Cap Growth C
AFAVX14.42N/A
N/A
AMG River Road Focused Absolute Value I